The Cancer Genetics Tissue of Origin Test is an in vitro diagnostic intended to measure the degree of similarity between the RNA expression patterns in a patient's formalin-fixed, paraffin-embedded (FFPE) tumor and the RNA expression patterns in a database of fifteen tumor types (poorly differentiated, undifferentiated and metastatic cases) that were diagnosed according to then current clinical and pathological practice. This test should be evaluated by a qualified physician in the context of the patient's clinical history and other diagnostic test results.
Cancer:
Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Non Small Cell Lung Cancer, Non-Hodgkin’s Lymphoma, Prostate Cancer